Literature DB >> 971485

Induction of erythroid differentiation in vitro by purines and purine analogues.

J F Gusella, D Housman.   

Abstract

The effectiveness of purines and purine analogues as inducers of erythroid differentiation in cultured murine erythroleukemia cells has been investigated. These cell lines have previously been shown to differentiate in vitro in response to dimethylsulfoxide (DMSO) and a number of other polar solvents. Two purine analogues, 6-thioguanine and 6-mercaptopurine, as well as the naturally occuring purine, purine, hypoxanthine, are shown to be extremely potent inducers. 6-Thioguanine is effective at a concentration of 0.06 mM, 750 fold lower than the DMSO concentration required for equivalent induction. 6-Mercaptopurine and hypoxanthine are effective inducers at a concentration of approximately 2 mM. Accumulation of globin mRNA was monitored during induction with purine inducers and shown to be similar in amount to globin mRNA levels reached in DMSO-induced cultures. Induction of differentiation by all three compounds follows a similar time course to induction with DMSO. All three compounds are potent inducers of HGPRT (hypoxanthine-guanine phosphoribosyltransferase)-negative cell lines; hence incorporation of purines into DNA is not required for induction of differentiation. Comparison of these compounds with other purines and purine analogues suggests a high degree of specificity in their interaction with a cellular target.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971485     DOI: 10.1016/0092-8674(76)90010-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  37 in total

1.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Inducers of mammalian cell differentiation stimulate dome formation in a differentiated kidney epithelial cell line (MDCK).

Authors:  J E Lever
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  Anion transport during maturation of erythroblastic cells.

Authors:  R G Kirk; P Lee
Journal:  J Membr Biol       Date:  1988       Impact factor: 1.843

4.  Cell cycle perturbating agents in a line of human thyroid transformed cells in culture (HuT).

Authors:  A Mancini; M R Faraone-Mennella; P Quesada; M Malanga; B Farinai
Journal:  Mol Cell Biochem       Date:  1991-05-15       Impact factor: 3.396

5.  Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells.

Authors:  B T French; D E Patrick; M R Grever; R W Trewyn
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Selective enrichment of specific DNA, cDNA and RNA sequences using biotinylated probes, avidin and copper-chelate agarose.

Authors:  A A Welcher; A R Torres; D C Ward
Journal:  Nucleic Acids Res       Date:  1986-12-22       Impact factor: 16.971

7.  Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds.

Authors:  M Terada; H Fujiki; P A Marks; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

8.  Methylated oxypurines and induction of differentiation of murine erythroleukemia cells.

Authors:  S J Kerr
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

9.  Induction and inhibition of Friend erythroleukemia cell differentiation by pyrimidine analogs: analysis of the requirement for intracellular accumulation and incorporation into DNA.

Authors:  J A Bilello; K K Gauri; J Kühne; G Warnecke; G Koch
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

10.  Development of an O(6)-alkylguanine-DNA alkyltransferase assay based on covalent transfer of the benzyl moiety from [benzene-3H]O(6)-benzylguanine to the protein.

Authors:  Kimiko Ishiguro; Krishnamurthy Shyam; Philip G Penketh; Alan C Sartorelli
Journal:  Anal Biochem       Date:  2008-08-20       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.